OR WAIT null SECS
Jill Murphy is Editor of Pharmaceutical Technology.
June 08, 2023
The document builds on key concepts outlined in ICH E8(R1) General Considerations for Clinical Studies.
June 05, 2023
Adamis Pharmaceuticals announced the closing of its merger with DMK Pharmaceuticals on May 25, 2023.
June 01, 2023
Through the acquisition, Avacta gains Coris’ product portfolio consisting of diagnostic tests for respiratory, gastroenteric, and blood-borne pathogens as well as for the detection of antibiotic resistance markers.
May 31, 2023
Under the new MTA and Option License Agreement, Adcendo can nominate ADCs against two novel ADC targets, according to the press release.
The project is being coordinated by the recently formed not-for-profit CCRM Nordic AB and gathers engaged stakeholders to move the initiative forward.
May 26, 2023
Paxlovid is not approved or authorized for use as a pre-exposure or post-exposure prophylaxis for prevention of COVID-19.